BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18645366)

  • 1. Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation.
    Kindgen-Milles D; Kram R; Kleinekofort W; Morgera S
    ASAIO J; 2008; 54(4):442-4. PubMed ID: 18645366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
    Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study.
    Gubensek J; Buturovic-Ponikvar J; Ponikvar R
    Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
    Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
    Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure.
    Morgera S; Scholle C; Melzer C; Slowinski T; Liefeld L; Baumann G; Peters H; Neumayer HH
    Nephron Clin Pract; 2004; 98(1):c35-40. PubMed ID: 15361702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.
    Durão MS; Monte JC; Batista MC; Oliveira M; Iizuka IJ; Santos BF; Pereira VG; Cendoroglo M; Santos OF
    Crit Care Med; 2008 Nov; 36(11):3024-9. PubMed ID: 18824904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
    Buturović-Ponikvar J; Gubensek J; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate for long-term hemodialysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients.
    Apsner R; Buchmayer H; Gruber D; Sunder-Plassmann G
    Am J Kidney Dis; 2005 Mar; 45(3):557-64. PubMed ID: 15754278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrate kinetics in patients receiving long-term hemodialysis therapy.
    Bauer E; Derfler K; Joukhadar C; Druml W
    Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis.
    Gradwohl-Matis I; Franzen M; Seelmaier C; Brunauer A; Dankl D; Dünser MW; Salmhofer H
    ASAIO J; 2015; 61(2):219-23. PubMed ID: 25485561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated regional citrate anticoagulation: technological barriers and possible solutions.
    Szamosfalvi B; Frinak S; Yee J
    Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis.
    Thijssen S; Kossmann RJ; Kruse A; Kotanko P
    Blood Purif; 2013; 35(1-3):133-8. PubMed ID: 23343558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
    Evenepoel P; Maes B; Vanwalleghem J; Kuypers D; Messiaen T; Vanrenterghem Y
    Am J Kidney Dis; 2002 Feb; 39(2):315-23. PubMed ID: 11840372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model of regional citrate anticoagulation in hemodialysis.
    Thijssen S; Kruse A; Raimann J; Bhalani V; Levin NW; Kotanko P
    Blood Purif; 2010; 29(2):197-203. PubMed ID: 20093827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.
    Antonic M; Gubensek J; Buturović-Ponikvar J; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):322-6. PubMed ID: 19695068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation for intermittent predilution online hemofiltration.
    Gubensek J; Buturović-Ponikvar J; Skofic N; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):306-9. PubMed ID: 19695064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration.
    Hetzel GR; Taskaya G; Sucker C; Hennersdorf M; Grabensee B; Schmitz M
    Am J Kidney Dis; 2006 Nov; 48(5):806-11. PubMed ID: 17060000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.